Literature DB >> 4319095

Biological significance of renin angiotensin immunization.

C I Johnston, J S Hutchinson, F A Mendelsohn.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 4319095

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


× No keyword cloud information.
  7 in total

1.  Disturbances of the control of renin secretion in chronic one-kidney-Goldblatt hypertension in the rat.

Authors:  U Helmchen; U Kneissler; G Peters
Journal:  Pflugers Arch       Date:  1974-04-22       Impact factor: 3.657

2.  Response of the kallikrein-kinin and renin-angiotensin systems to saline infusion and upright posture.

Authors:  P Y Wong; R C Talamo; G H Williams; R W Colman
Journal:  J Clin Invest       Date:  1975-04       Impact factor: 14.808

3.  Active immunization with angiotensin I peptide analogue vaccines selectively reduces the pressor effects of exogenous angiotensin I in conscious rats.

Authors:  S M Gardiner; T R Auton; M R Downham; H L Sharp; P A Kemp; J E March; H Martin; P J Morgan; A Rushton; T Bennett; J F Glover
Journal:  Br J Pharmacol       Date:  2000-03       Impact factor: 8.739

Review 4.  Vaccination: a novel strategy for inhibiting the renin-angiotensin-aldosterone system.

Authors:  Alan H Gradman; Rehka Pinto
Journal:  Curr Hypertens Rep       Date:  2008-12       Impact factor: 5.369

5.  Angiotensin II vascular receptors: their avidity in relationship to sodium balance, the autonomic nervous system, and hypertension.

Authors:  H R Brunner; P Chang; R Wallach; J E Sealey; J H Laragh
Journal:  J Clin Invest       Date:  1972-01       Impact factor: 14.808

Review 6.  Vaccine Development against the Renin-Angiotensin System for the Treatment of Hypertension.

Authors:  Tatsuhiko Azegami; Hiroshi Itoh
Journal:  Int J Hypertens       Date:  2019-08-14       Impact factor: 2.420

7.  Role of extrapulmonary conversion in mediating the systemic pressor activity of angiotensin I.

Authors:  H F Oates; G S Stokes
Journal:  J Exp Med       Date:  1974-07-01       Impact factor: 14.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.